期刊文献+

盐酸特拉唑嗪对细菌性前列腺炎模型大鼠血浆中左氧氟沙星浓度的影响 被引量:5

Influence of Terazosin on Plasma Concentration of Levofloxacin in Rats with Bacterial Prostatitis
原文传递
导出
摘要 目的:研究盐酸特拉唑嗪对细菌性前列腺炎模型大鼠血浆中左氧氟沙星浓度的影响,并探讨二者协同作用机制。方法:取大鼠建立细菌性前列腺炎模型,随机分为实验组与对照组,每组60只,实验组大鼠灌服盐酸特拉唑嗪溶液(0.44mg·kg-1),对照组同时灌服溶媒,12h后重复1次并立即给2组大鼠静脉注射左氧氟沙星溶液(44mg·kg-1),分别于注射给药后1、3、7.5、15、30、60、120、240、480、720min断头取血,采用高效液相色谱法测定其中左氧氟沙星血药浓度。结果:与对照组比较,实验组大鼠血浆中左氧氟沙星浓度无显著性差异(P>0.05)。结论:盐酸特拉唑嗪对细菌性前列腺炎模型大鼠血浆中左氧氟沙星的浓度无明显影响,前者不是通过增加后者的血药浓度,而可能是通过增加后者在组织中的浓度来提高治疗前列腺炎的效果。 OBJECTIVE: To study the influence of terazosin on plasma concentration of levofloxacin in rats with bacterial prostatitis, and to discuss the corporation mechanism of terazosin and levofloxacin. METHODS: Bacterial prostatitis model had been established and randomly divided rats into experimental group and control group (n=60). Experimental group was given terazosin 0.44 mg·kg-1 for oral administration and control group was given solvent. Both groups were given drugs once more after 12 h and injected with levofloxacin 44 mg·kg-1 immediately. Plasma sample was collected 1, 3, 7.5, 15, 30, 60, 120, 240, 480 and 720 min after administration. The plasma concentration of levofloxacin was detected by HPLC. RESULTS: There was no significant difference in plasma concentration of levofloxacin between two groups (P0.05). CONCLUSION: Terazosin has no significant influence on plasma concentration of levofloxacin in rats with bacterial prostatitis, and terazosin improves the effect of levofloxacin on prostatitis by increasing the concentration of levofloxacin in tissue not in plasma.
出处 《中国药房》 CAS CSCD 北大核心 2011年第5期408-410,共3页 China Pharmacy
关键词 盐酸特拉唑嗪 左氧氟沙星 细菌性前列腺炎 高效液相色谱法 大鼠 血药浓度 Terazosin Levofloxacin Bacterial prostatitis HPLC Rats Plasma concentration
  • 相关文献

参考文献8

二级参考文献17

  • 1沈柏华,金晓东,蔡松良,陈军,陈戈明,赵伟平,孙欣.α1受体阻滞剂联合抗生素治疗慢性前列腺炎疗效及机制[J].中华男科学杂志,2004,10(7):518-520. 被引量:57
  • 2吴金虎,张晓燕,肖雨清,王刚.大鼠前列腺炎模型的建立[J].山西医药杂志,2006,35(3):193-194. 被引量:17
  • 3NICKEL JC. Inflammatory conditions of the male genitourinary tract: proatatitis and related conditions, orchitis, and epididymitis [M]//WEIN AJ. Campbell-Walsh Urology. Philadelphia: Tina Rcbane, 2007: 304-305.
  • 4BARBALIAS GA, NIKIFORIDIS G, LIATSIKOS EN. Alphablock-ers for the treatment of chronic prostatitis in combination with antibiotics[J]. J Urol, 1998, 159(3): 883-887.
  • 5ROMICS I. The role of alpha-adrenoreceptors in the treatment of urological diseases[J]. Neurochem Int, 2007, 51(5): 328-331.
  • 6ELKAHWAJI JE, OTF C J, JANDA LM, et ol. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains[J]. Urology, 2005, 66(4): 883-887.
  • 7杨藻宸.选择性肾上腺素受体阻断药[M]//杨藻宸.医用药理学:上册.北京:人民卫生出版社,2005:178-179.
  • 8KRIEGER JN, RILEY DE, ROBERES MC, et al. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis [J].J Clin Micro, 1996, 34: 3120-3128.
  • 9安黎明,江鱼.盐酸坦索罗辛对慢性前列腺炎患者尿流率的影响[J].临床泌尿外科杂志,2001,16(3):142-143. 被引量:11
  • 10吴荣佩,郑克立,胡红星,张锦占,邓春华.α_(1A)受体阻滞药治疗慢性前列腺炎疗效观察[J].临床泌尿外科杂志,2001,16(5):207-208. 被引量:20

共引文献19

同被引文献40

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部